FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steve Boccuzzi

Research Profile

Disorders

Chemicals & Drugs

Procedures

Phenomena

Recurrence

Activities & Behaviors

Cost Benefit Analysis

Concepts & Ideas

Geographic Areas

Organizations

Insurance, Pharmaceutical Services

Co-author Network

Publications

TOP 3
Craig Jones; Nancy C Santanello; Steve J Boccuzzi; Jenifer Wogen; Peg Strub; Linda Nelsen
Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data.
Paul R Conlin; W C Gerth; J Fox; JB Roehm; Steve J Boccuzzi
Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes.
Steve J Boccuzzi; Jenifer Wogen; J Fox; J C Sung; A B Shah; J Kim
Utilization of oral hypoglycemic agents in a drug-insured U.S. population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steve Boccuzzi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Craig Jones; Nancy C Santanello; Steve J Boccuzzi; Jenifer Wogen; Peg Strub; Linda Nelsen
Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data.
The Journal of asthma : official journal of the Association for the Care of Asthma 2003;40(1):93-101.
2001: Paul R Conlin; W C Gerth; J Fox; JB Roehm; Steve J Boccuzzi
Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes.
Clinical therapeutics 2001;23(12):1999-2010.
2001: Steve J Boccuzzi; Jenifer Wogen; J Fox; J C Sung; A B Shah; J Kim
Utilization of oral hypoglycemic agents in a drug-insured U.S. population.
Diabetes care 2001;24(8):1411-5.
2000: Antonio M Gotto; Steve J Boccuzzi; J R Cook; Charles M Alexander; JB Roehm; G S Meyer; Michael Clearfield; S Weis; EJ Whitney
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.
The American journal of cardiology 2000;86(11):1176-81.
2000: William S Weintraub; Trevor D Thompson; Steven D Culler; Steve J Boccuzzi; Edmund R Becker; Andrzej S Kosinski; Elizabeth M Mahoney
Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support model.
Circulation 2000;102(4):392-8.
2000: Steve J Boccuzzi; Jenifer Wogen; JB Roehm
Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
Clinical therapeutics 2000;22(2):237-47.
1999: Steven M Haffner; Charles M Alexander; Thomas J Cook; Steve J Boccuzzi; Thomas A Musliner; Terje R Pedersen; John Kjekshus; Kalevi Pyörälä
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
Archives of internal medicine 1999;159(22):2661-7.
1999: William H Herman; Charles M Alexander; John R Cook; Steve J Boccuzzi; Thomas A Musliner; Terje R Pedersen; John Kjekshus; Kalevi Pyörälä
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
Diabetes care 1999;22(11):1771-8.
1999: William S Weintraub; Steven D Culler; Steve J Boccuzzi; J R Cook; Andrzej S Kosinski; D J Cohen; JC Burnette
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
Journal of the American College of Cardiology 1999;34(4):1061-6.
1999: William S Weintraub; Christi Deaton; L Shaw; Elizabeth M Mahoney; Douglas C Morris; C Saunders; D Canup; S Connolly; Steven D Culler; Edmund R Becker; Andrzej S Kosinski; Steve J Boccuzzi
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?
The American journal of cardiology 1999;84(2):166-9.
1999: Carla A Sueta; Mridul Chowdhury; Steve J Boccuzzi; Sidney C Smith; Charles M Alexander; A Londhe; A Lulla; Ross J Simpson
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.
The American journal of cardiology 1999;83(9):1303-7.
1999: William S Weintraub; Steven D Culler; Andrzej S Kosinski; Edmund R Becker; Elizabeth M Mahoney; JC Burnette; John A Spertus; David Feeny; D J Cohen; Harlan Krumholz; S G Ellis; Laura A Demopoulos; D Robertson; Steve J Boccuzzi; Eliav Barr; Christopher P Cannon
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial.
The American journal of cardiology 1999;83(3):317-22.
1998: Steve J Boccuzzi; William S Weintraub; Andrzej S Kosinski; JB Roehm; J Larry Klein
Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial).
The American journal of cardiology 1998;81(5):632-6.
1997: Ross J Simpson; Carla A Sueta; Steve J Boccuzzi; A Lulla; David P Biggs; A Londhe; Sidney C Smith
Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction.
The American journal of cardiology 1997;80(8B):53H-56H.
1997: William S Weintraub; C D Warner; Patrick D Mauldin; Edmund R Becker; Daniel Gomes; J Cook; A Kosinski; Steve J Boccuzzi
Economic winners and losers after introduction of an effective new therapy depend on the type of payment system.
The American journal of managed care 1997;3(5):743-9.
1996: R Waksman; Andrzej S Kosinski; L Klein; Steve J Boccuzzi; Spencer B King; Ziyad Ghazzal; William S Weintraub
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
The American journal of cardiology 1996;78(2):221-4.
1996: J Larry Klein; Steve J Boccuzzi; C B Treasure; S V Manoukian; Robert A Vogel; G J Beauman; D Fischman; M P Savage; W S Weintaub
Performance standards and edge detection with computerized quantitative coronary arteriography. The Lovastatin Restenosis Trial Group.
The American journal of cardiology 1996;77(10):815-22.
1996: S P Gilbert; William S Weintraub; J D Talley; Steve J Boccuzzi
Costs of coronary restenosis (Lovastatin Restenosis Trial).
The American journal of cardiology 1996;77(2):196-9.
1995: C B Treasure; J Larry Klein; William S Weintraub; J D Talley; M E Stillabower; Andrzej S Kosinski; J Zhang; Steve J Boccuzzi; J C Cedarholm; Wayne R Alexander
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.
The New England journal of medicine 1995;332(8):481-7.
1994: William S Weintraub; Steve J Boccuzzi; J Larry Klein; Andrzej S Kosinski; Spencer B King; R Ivanhoe; J C Cedarholm; M E Stillabower; J D Talley; S J DeMaio
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
The New England journal of medicine 1994;331(20):1331-7.
1992: William S Weintraub; Steve J Boccuzzi; C L Brown; C L Cohen; L J Hirsch; Spencer B King; Wayne R Alexander
Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group.
The American journal of cardiology 1992;70(3):293-9.